Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila  by Gunawardena, Shermali et al.
Neuron, Vol. 40, 25–40, September 25, 2003, Copyright 2003 by Cell Press
Disruption of Axonal Transport
by Loss of Huntingtin or Expression
of Pathogenic PolyQ Proteins in Drosophila
transcription factors, caspases, and molecular chaper-
ones and other proteins, which may stimulate apoptosis.
We previously found that expression in Drosophila
of proteins that cause Alzheimer’s disease in humans
disrupts axonal transport and induces neuronal cell
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Huntingtin is a cytoplasmic protein with unknownUniversity of Pennsylvania
Philadelphia, Pennsylvania 19104 functions. In mice, deletion of the huntingtin gene results
in early embryonic lethality, whereas later deletion of
huntingtin by conditional mutagenesis causes neuronal
degeneration (Dragatsis et al., 2000; Duyao et al., 1995;Summary
Nasir et al., 1995; Zeitlin et al., 1995). In rat sciatic nerve
axons, huntingtin is transported in both anterograde andWe tested whether proteins implicated in Huntington’s
and other polyglutamine (polyQ) expansion diseases retrograde pathways (Block-Galarza et al., 1997). Immu-
nohistochemical studies in human and rat brains revealcan cause axonal transport defects. Reduction of Dro-
sophila huntingtin and expression of proteins con- cytoplasmic huntingtin within neurons, and biochemical
analysis indicates that huntingtin is enriched in compart-taining pathogenic polyQ repeats disrupt axonal trans-
port. Pathogenic polyQ proteins accumulate in axonal ments containing vesicle-associated proteins (DiFiglia
et al., 1995, 1997). Huntingtin interacts with many pro-and nuclear inclusions, titrate soluble motor proteins,
and cause neuronal apoptosis and organismal death. teins, including nuclear, transcriptional, and signaling
proteins (Cattaneo et al., 2001; Freiman and Tjian, 2002).Expression of a cytoplasmic polyQ repeat protein
causes adult retinal degeneration, axonal blockages One protein of particular interest is the huntingtin-asso-
ciated protein 1 (HAP1; Li et al., 1996). Although itsin larval neurons, and larval lethality, but not neuronal
apoptosis or nuclear inclusions. A nuclear polyQ re- function is unknown, HAP1 is also transported in both
anterograde and retrograde pathways (Block-Galarza etpeat protein induces neuronal apoptosis and larval
lethality but no axonal blockages. We suggest that al., 1997) and is found associated with vesicle mem-
branes in synaptosomal fractions, indicating that thepathogenic polyQ proteins cause neuronal dysfunc-
tion and organismal death by two non-mutually exclu- HAP1 interaction with huntingtin may occur within axons
(Engelender et al., 1997). Additionally, HAP1 stronglysive mechanisms. One mechanism requires nuclear
accumulation and induces apoptosis; the other inter- associates with p150Glued, a critical component of the
dynein-based transport system (Engelender et al., 1997;feres with axonal transport. Thus, disruption of axonal
transport by pathogenic polyQ proteins could contrib- Li et al., 1998). Recent work suggests a role for a Dro-
sophila HAP1-like protein in kinesin-dependent trans-ute to early neuropathology in Huntington’s and other
polyQ expansion diseases. port of mitochondria (Stowers et al., 2002). Together,
these findings lead to the still untested suggestion that
huntingtin has an important function in the axonal trans-Introduction
port machinery itself.
In HD brain, aggregates of mutant huntingtin are ob-Huntington’s disease (HD) is one of nine neurodegenera-
tive diseases that result from the expansion of CAG served in nuclear inclusions and in dystrophic neurites
(DiFiglia et al., 1997; Becher et al., 1998). In HD trans-repeats leading to proteins containing abnormally long
polyQ tracts. Although little is known about the mecha- genic mice, N-terminal huntingtin fragments and their
nism by which polyQ expansion leads to pathogenesis, it aggregates initially accumulate in striatal neurons, and
has been proposed that misfolding of the mutant protein later these neurons form aggregates in axonal pro-
triggers a cascade of events, ultimately causing disease. cesses and terminals (Li et al., 2000). Neuropil aggre-
The misfolded protein may undergo proteolytic cleav- gates were observed in the striatum in the lateral globus
age, interact with other proteins, self-aggregate, and pallidus (LGP), a region into which medium spiny neu-
in many cases, translocate into the nucleus. Indeed, rons project. How a function that may normally be asso-
a common characteristic of all polyQ diseases is the ciated with cytoplasmic vesicles can contribute to nu-
formation of nuclear or cytoplasmic and axonal or den- clear dysfunction and whether this reflects a normal
dritic inclusions of the disease protein (Li et al., 2000, nuclear signaling role of huntingtin is unknown. A testa-
2001; Piccioni et al., 2002; Paulson et al., 1997; Becher ble possibility is that (1) normal huntingtin has a role in
et al., 1998; Ishikawa et al., 1999). In the nucleus, aggre- axonal transport and (2) mutant huntingtin, and possibly
gated polyQ proteins have been suggested to recruit other pathogenic polyQ proteins, cause neuronal dys-
function by poisoning vesicular transport within neu-
rons, which can ultimately contribute to neurodegenera-*Correspondence: lgoldstein@ucsd.edu
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tion. Here we directly test this hypothesis in vivo in eye phenotype in adults, which is also characteristic
of neurodegeneration (Figure 1D). This phenotype wasDrosophila.
progressive over time (10 days), causing severe prob-
lems of morphology and pigmentation, leading to patchesResults
of dark areas indicative of death. Sections of aged mu-
tant eyes showed loss of cells beneath the externalReduction of Drosophila Huntingtin Expression
surface of the eye and disruption in the normal ommatid-Causes Axonal Transport Defects in Larval Nerves
ial morphology, suggesting loss of photoreceptor integ-and Neurodegeneration in Adult Eyes
rity. These results suggest that htt has a function in theDrosophila larvae with mutations in genes encoding ax-
axonal transport machinery and that loss of htt can leadonal transport proteins show dramatic neuromuscular
to neurodegeneration.pathology. Segmental nerves of such mutant animals
contain prominently stained accumulations of synaptic
Expression of Human Huntingtin Exon 1vesicle proteins such as synaptotagmin (SYT) and cys-
with Expanded PolyQ Repeats Causesteine string protein (CSP) (Hurd and Saxton, 1996; Bow-
Axonal Transport Defectsman et al., 1999). Recently, deletion of the Drosophila
The observation that reduction of htt causes an axonalAPPL gene, which is proposed to function as a vesicular
transport phenotype, combined with previous work link-receptor for kinesin-I, was found to exhibit phenotypes
ing htt to the transport machinery, leads to the hypothe-characteristic of axonal transport defects (Gunawar-
sis that excess htt, particularly htt containing pathogenicdena and Goldstein, 2001). To test if reduction of
polyQ repeats, should cause axonal blockages by titrat-Drosophila huntingtin (htt) causes axonal transport phe-
ing motor proteins away from other cargo. To test thisnotypes, we generated tissue-specific reduction of Dro-
proposal, we expressed human huntingtin exon 1 withsophila htt by using a modified RNAi method (Figure 1A;
either a “normal” length of polyQ (httex1-20Q) or with aPiccin et al., 2001). Three independent UAS double-
disease-causing length of polyQ (httex1-93Q; Steffan etstrand htt hairpin RNAi transgenic lines (dhtt#1, #9, and
al., 2001) in larval neurons. These transgenic lines were#13) were combined with the neuronal APPL-GAL4
crossed to two neuron-specific GAL4 driver lines, APPL-driver. Expression of htt RNA in the dhtt-RNAi lines was
GAL4 and 179Y-GAL4, and their nerves were stainedobserved by RT-PCR to be reduced, in some instances
for synaptic vesicle markers. While httex1-20Q nervesto as little as 10%–30% of normal (see Supplemental
were similar to wild-type, two different httex1-93Q linesFigure S1B at http://www.neuron.org/cgi/content/full/
had organelle accumulations characteristic of defects in40/1/25/DC1). All three lines exhibited defects charac-
axonal transport (Figure 2A; Supplemental Figure S1A atteristic of axonal transport problems (organelles accu-
http://www.neuron.org/cgi/content/full/40/1/25/DC1).mulate within larval nerves) as well as a small amount
If expression of httex1 with pathogenic polyQ repeatsof neuronal cell death in the larval brain (Figures 1B
causes axonal transport phenotypes by titrating motorand 1C; Supplemental Figure S1A; data not shown). As
proteins from other cargoes and pathways, then reduc-controls, UAS double-strand RNAi lines of RhoGAP (Bil-
tion of motor protein gene dosage in larvae overexpress-luart et al., 2001) were combined with APPL-GAL4.
ing httex1 is predicted to significantly enhance theThese combinations did not cause axonal transport de-
axonal transport phenotype by further reducing thefects, although disruption of RhoGAP in the adult eye
available motor protein pool. To test this prediction,using GMR-GAL4 or eyeless-GAL4 caused a rough eye
we generated larvae that overexpressed httex1-20Q orphenotype (data not shown).
httex1-93Q and were heterozygous for motor proteinOrdinarily, deleting one of two copies of motor genes
gene mutations. A 50% reduction in KHC or DLC withdoes not have a significant phenotype, but such a reduc-
httex1-93Q enhanced the amount of organelle accumu-tion combined with a reduction of a putative cargo bind-
lations, while KHC or DLC reductions combined withing partner is predicted to enhance an axonal transport
httex1-20Q were comparable to wild-type (Figure 2A;phenotype because of the additional reduction in com-
Supplemental Figure S1A).ponents required for transport. To test this prediction,
We used TUNEL analysis to test whether perturba-we generated larvae that had reduced levels of both htt
tions caused by httex1 causes neuronal apoptosis.and motor proteins. Axonal blockages in the presence
While the transgenic line expressing httex1-20Q wasof reduced htt gene function were enhanced by a 50%
comparable to wild-type, the transgenic lines express-reduction in kinesin heavy chain (KHC) or kinesin light
ing httex1-93Q showed some neuronal apoptosis (Fig-chain (KLC) gene dosage; a small enhancement of neu-
ure 2B); a strong enhancement of neuronal death wasronal cell death was also observed. A 50% reduction of
also observed with 50% reduction in KHC and a smalldynein heavy chain (DHC) or dynein light chain gene
increase with 50% reduction in DLC.(DLC) dose did not dramatically increase the amount of
organelle accumulations or the amount of neuronal cell
death (Figures 1B and 1C; Supplemental Figure S1A; Pathogenic PolyQ Proteins Cause Axonal
Transport Defects and Neuronal Apoptosisdata not shown).
Since adults and pupae mutant for DLC (Bowman et To address whether axonal transport defects were se-
lective to the pathogenic htt protein, or whether theyal., 1999), dynein intermediate chain (Boylan et al., 2000),
and the dominant-negative mutation p150Glued have were a feature of polyQ proteins in general, we examined
the effects on axonal transport of various proteins con-rough eye phenotypes, we asked if loss or disruption
of htt would also exhibit this phenotype. Reduction of taining polyQ tracts of different lengths and in different
contexts. 179Y-GAL4 and APPL-GAL4 were crossed tohtt in the eye using the GMR-GAL4 driver caused a rough
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Figure 1. Reduction of Drosophila Huntingtin
Causes Axonal Transport Defects and Neuro-
degeneration
(A) The UAS double-strand RNAi construct
contains 1 kb each of sense and antisense
DNA from the N-terminal region of the Dro-
sophila htt gene (blue) separated by 300 bp
of linker DNA from GFP (green).
(B) Two RNAi lines, dhtt#1 and dhtt#9, with
APPL-GAL4 show organelle accumulations
within larval segmental nerves (arrows) simi-
lar to DHC/ larvae when stained with synap-
tic marker CSP. Segmental nerves from wild-
type larvae stain smoothly. 50% reduction of
KHC with RNAi lines dhtt#1 and dhtt#9
(dhtt#1;KHC/ and dhtt#9;KHC/) enhance
the organelle accumulation phenotype. Lar-
vae that are KHC/ show extensive accu-
mulations while larvae that are KHC/ are
normal. 50% reduction of DLC with RNAi
lines dhtt#1 and dhtt#9 (dhtt#1;DLC/ and
dhtt#9;DLC/) does not significantly en-
hance the organelle accumulation pheno-
type. Larvae that are DLC/ show extensive
accumulations while larvae that are DLC/
are normal. Scale bar equals 10 m.
(C) Cell death assayed by TUNEL analysis
shows some neuronal cell death within
the larval brains of dhtt#1 and dhtt#9.
Some neuronal death is observed in dhtt#1;
KHC/, dhtt#9;KHC/, dhtt#1;DLC/, and
dhtt#9;DLC/. (VG, ventral ganglion). Scale
bar equals 10 m.
(D) Disruption of Drosophila htt causes de-
generation in the adult eye. The rough eye
phenotype is observed in dhtt#1 and dhtt#9
with GMR-GAL4 compared to wild-type (GMR-
GAL4/Oregon R). The rough eye phenotype
becomes progressively worse as the flies age
(10 days). Frontal sections of 10 day dhtt#1
and dhtt#9 flies show cell degeneration in the
retina (R, arrows) with severely disrupted in-
ternal morphology. Brain regions lamina (L)
and medulla (M) appear normal. Large holes
(arrowheads) are visible in the most lateral
part of the lamina. Tangental sections through
the eyes of 10 day dhtt#1 and dhtt#9 show
loss of cell morphology of the rhabdomere
lattice compared to wild-type (GMR-GAL4/
Oregon R).
lines encoding proteins with either a “normal” length, MJD-78Q; Warrick et al., 1998). We found that proteins
with normal length polyQ regions (22Q, MJD-27Q) werenondisease-causing polyQ repeat region or proteins
with an expanded, disease-causing polyQ repeat region. present within axons based upon the smooth staining
seen with either an antibody against polyQ or an anti-These proteins consisted either entirely of polyQ repeats
(20Q, 22Q, 108Q, 127Q; Marsh et al., 2000; Kazemi- body against the HA tag (Figure 3A) and that these pro-
teins accumulate at neuromuscular junctions (FigureEsfarjani and Benzer, 2000) or polyQ repeats embedded
in the C-terminal region of the MJD protein (MJD-27Q, 3B), suggesting that they are normally transported within
Neuron
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Figure 2. Overexpression of Human Hunting-
tin Exon 1 with Expanded PolyQ Repeats Re-
sults in Axonal Transport Defects and Neu-
ronal Cell Death
(A) Expression of httex1-20Q resulted in a
normal phenotype indistinguishable from
wild-type, while two different lines on the sec-
ond and third chromosome expressing
httex1-93Q showed organelle accumulations
with CSP (arrows). Accumulations were en-
hanced with 50% reduction of KHC (httex1-
93Q;KHC/). 50% reduction of DLC also
exhibited accumulations but there was no
significant increase in the amount of accumu-
lations (httex1-93Q;DLC/). Scale bar equals
10 m.
(B) Expression of httex1-93Q caused neu-
ronal cell death, which was enhanced by 50%
reduction of KHC. 50% reduction of DLC did
not dramatically enhance neuronal death. Ex-
pression of httex1-20Q was comparable to
wild-type and no phenotypic change was ob-
served with 50% reduction in KHC or DLC.
larval axons. In contrast, proteins with expanded polyQ the expression of MJD-78Q and 127Q at 29C was very
toxic such that larvae expressing these proteins neverrepeats (MJD-78Q, 127Q) exhibited prominent polyQ
staining within organelle blockages (Figure 3A), while survived to adulthood and died at second or third instar
larval stage. Western blot analysis ruled out a generalreduced staining was observed at the neuromuscular
junctions (Figure 3B), suggesting impaired transport of expression difference between proteins with normal
length polyQ repeats and proteins with expanded polyQpathogenic polyQ proteins.
The extent of axonal accumulations induced by polyQ repeats since, if anything, more MJD-27Q expression
was observed compared to MJD-78Q (Figure 5B). Torepeats was length dependent, as we observed a corre-
lation between the number of polyQ repeats and the reduce the level of toxicity, we reduced the amount of
MJD-78Q and 127Q made by growing animals at 25Camount of axonal accumulations (Supplemental Figures
S2A and S2B at http://www.neuron.org/cgi/content/full/ (GAL4 activity is temperature dependent; Phelps and
Brand, 1998). We still observed organelle accumulations40/1/25/DC1). Larvae expressing 20Q, 22Q, or MJD-27Q
were similar to wild-type in that they exhibited no axonal although these larvae now survived much longer, dying
at early pupal stages (data not shown).accumulations. Larvae expressing the pathogenic pro-
teins MJD-78Q, 108Q, or 127Q exhibited a severe slug- To confirm the results seen by immunofluorescent
staining, we conducted EM analysis on larvae express-gish larval movement phenotype, with prominent axonal
accumulations observed in all instances (Figure 3A; Sup- ing 127Q and on severe genotypes in which expression
of MJD-78Q or 127Q was combined with a 50% reduc-plemental Figures S2A and S2B). We also observed that
Axonal Transport and PolyQ Proteins
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Figure 3. Nonpathogenic PolyQ Proteins Are Transported Normally within Larval Nerves, while Pathogenic PolyQ Proteins Are Not
(A) Nonpathogenic polyQ proteins are present within larval nerves, while pathogenic polyQ proteins (anti-HA, red) are found within organelle
accumulations (anti-SYT, green). Excess 127Q with 50% reduction in KHC enhances 127Q containing organelle accumulations. Scale bar
equals 10 m.
(B) Nonpathogenic polyQ proteins are transported to the neuromuscular junctions while pathogenic polyQ proteins are not (arrows). Complete
blockage is observed with 50% reduction of KHC with 127Q.
tion in KHC gene dose (see below). We observed promi- 78Q, using the GAL4 driver pGAL4-62B SG26-1, which
is expressed in only a small population of motor neuronsnent axonal blockages characteristic of those observed
in homozygous mutations of motor protein genes (com- (R.G.B., unpublished data). Neurons expressing only
APP-YFP contained many actively motile vesicles mov-pare Figure 4A to Bowman et al. [1999] Figure 6 [DLC/]
and Hurd and Saxton [1996] Figure 2B [KHC/]). Mutant ing at velocities of approximately 1 m/s (Figure 4C;
Supplemental Figure S3 and Movies S1 and S2 at http://larval nerves also contained enlarged axons, some al-
most four or five times the diameter of those observed www.neuron.org/cgi/content/full/40/1/25/DC1); we
never observed any large bright nonmotile accumula-in wild-type. Sometimes we observed “holes” lacking
organelles within the nerve, perhaps indicative of degen- tions such as those seen in the presence of MJD-78Q
(below). Neurons coexpressing MJD-78Q and APP-YFPeration.
To test directly whether pathogenic polyQ proteins revealed nonmoving large, bright aggregates of APP-
YFP. Thus, polyQ expression can interfere with transportblock transport by inducing nonmoving blockages in
axonal processes, we performed live analysis of vesicu- of APP-YFP vesicles.
To test whether proteins with expanded polyQ repeatslar movement within whole-mount larval axons. We ex-
pressed YFP-tagged human amyloid precursor protein can induce neuronal apoptosis, we used TUNEL analy-
sis. A large increase in neuronal apoptosis was observed(APP-YFP) either in the presence or absence of MJD-
Neuron
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Figure 4. Expression of Pathogenic PolyQ Proteins Causes Organelle Accumulations and Neuronal Cell Death
(A–H) EM analysis shows organelle accumulations within one larval segmental nerve in lines expressing pathogenic polyQ proteins. In wild-
type, many axons can be observed (box) and organelles can be observed within them (dashed outline). In 127Q (G and H), MJD-78Q;KHC/
(C and D), and 127Q;KHC/ (E and F) nerve, organelle accumulations can be observed within axons (box and dashed outline). Only a few
axons can be observed and they are enlarged about four or five times that of wild-type (A and B). Scale bar equals 500 nm.
(B) Quantitative analysis depicts the extent of TUNEL-positive cells caused by expression of pathogenic polyQ proteins within the larval brain.
(C) Live analysis of YFP-tagged vesicle movement within whole-mount larvae expressing MJD-78Q compared to normal YFP vesicle movement.
Note the nonmoving large, bright APP-YFP aggregate in the neuron coexpressing MJD-78Q and APP-YFP. Asterisk, anterograde movement;
diamond, retrograde movement; thin arrow, nonmoving vesicle; broad arrow, nonmoving accumulation. Scale bar equals 10 m.
in lines expressing MJD-78Q and 127Q, but not in lines within larval brain cells (Supplemental Figure S2D). Many
stained nuclei were obviously enlarged and may be un-expressing the nonpathogenic control proteins 22Q or
MJD-27Q (Figure 4B; Supplemental Figure S2C). Anti- dergoing apoptosis. Expression during embryonic cycle
14 revealed smooth cytoplasmic staining for MJD-78QpolyQ staining revealed obvious nuclear inclusions
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protein, while staining for 127Q revealed obvious punc- sure the amount of each motor protein associated with
normal cargoes owing to the lack of information abouttate cytoplasmic aggregates with some nuclear aggre-
gates (Supplemental Figure S2E). At later cycles, both such cargoes and how such cargoes fractionate relative
to polyQ aggregates. Thus, we assessed soluble levelsMJD-78Q and 127Q were observed as punctate cyto-
plasmic and nuclear aggregates (data not shown). In of motor proteins under the hypothesis that aggregated
polyQ proteins may bind motor proteins and depleteaddition, embryos expressing both MJD-78Q and 127Q
died soon after they hatched into larvae, indicating sub- both soluble and cargo bound pools in parallel.
At 6 hr of development, we observed no significantstantial polyQ toxicity on normal development. Taken
together, these results confirm that proteins with ex- change in the amount of total motor protein present in
these embryos. In contrast to the normal amounts ofpanded polyQ repeats cause axonal transport defects,
perhaps by blocking axonal processes by polyQ accu- total motor proteins, we observed an obvious reduction
in the amount of soluble motor proteins in embryosmulations, neuronal cell death, and neurodegeneration.
expressing MJD-27Q, MJD-78Q, and 127Q compared
to wild-type embryos (i.e., da-GAL4 alone and yw; FigurePathogenic PolyQ Proteins May Titrate Motor
5A). The amount of soluble DHC, DIC, p150Glued, KHC,Proteins from Other Cargoes and Pathways
and KLC were reduced, with no change observed inIt is possible that polyQ proteins bind and deplete critical
tubulin, actin, HDAC3, and Rab8. However, for reasonscomponents of the molecular motor machinery, perhaps
that are not clear, syntaxin was upregulated. Similarvia a Drosophila version of HAP1. This hypothesis makes
observations were evident from 12 and 16 hr embryotwo predictions: (1) genetic reduction of motor protein
collections (data not shown). The effect of httex1-93Qdosage should worsen the phenotypes caused by pro-
expression on levels of soluble motor proteins was notteins with polyQ expansions by further depleting the
obvious at 6 hr of development (data not shown). How-motor protein supply; and (2) motor protein depletion
ever, at 18 hr of development, there is an obvious reduc-should be observable with biochemical methods.
tion in soluble p150Glued and KLC in embryos expressingTo test this hypothesis, we expressed proteins with
httex1-93Q but not httex1-20Q or wild-type. Expressionexpanded polyQ repeats and reduced levels of dynein
of polyQ proteins in embryos was obvious as detectedand kinesin. We found that while a 50% reduction in the
by anti-HA antibody and confirmed by anti-polyQ anti-dose of KHC has no significant phenotype on its own,
body (Figure 5B). The level of 127Q was difficult to evalu-when combined with pathogenic polyQ repeats, it dra-
ate, perhaps due to the formation of aggregates, andmatically enhanced the axonal organelle accumulation
was convincingly observed only after immunoprecipita-phenotype (Supplemental Figures S2A and S2B at http://
tion with anti-HA antibody (Figure 5C). These observa-www.neuron.org/cgi/content/full/40/1/25/DC1). Simi-
tions indicate that expanded polyQ proteins can depletelarly, while a 50% reduction in the dose of DLC or compo-
or sequester available soluble motor proteins, perhapsnents of the dynactin complex (p150Glued, Arp1, and dy-
into polyQ aggregates. The high expression level ofnamitin) also normally have no significant phenotypes
MJD-27Q in embryos and the observed depletion ofon their own, when combined with pathogenic polyQ
soluble motor proteins in these embryos are consistentproteins, these reductions substantially enhanced the
with the finding that axonal blockages can be observedorganismal phenotype leading to early larval lethality
in larvae expressing MJD-27Q when motor protein gene(Supplemental Figures S2A and S2B). This finding is
dose is reduced by 50% (Supplemental Figure S2Aconsistent with our observation that the neuronal APPL-
at http://www.neuron.org/cgi/content/full/40/1/25/GAL4 driver turns on during embryonic stage 15 as ob-
DC1). This finding is also consistent with the proposalserved by the expression pattern of UAS-GFP (data not
(see Discussion) that motor titration and aggregationshown). The enhanced lethality precluded analysis of
may act in concert to poison axonal transport.axonal transport in these genotypes. Interestingly, or-
ganelle accumulations now appeared in transgenic lines
expressing normally nonpathogenic poly Q repeats (22Q Enhanced Expression of Chaperones Restores
Neuronal Transport and Suppresses Cell Deathand MJD-27Q) with a 50% reduced dose of dynein (Sup-
plemental Figures S2A and S2B), consistent with the Caused by Pathogenic PolyQ Proteins
Previous work found that the neurodegenerative adulthypothesis that all of these proteins may titrate motor
proteins, but to varying extents (see below). To test eye phenotype caused by polyQ expansion proteins in
Drosophila is suppressed by excess chaperone proteinsdirectly for motor protein depletion mediated by expres-
sion of proteins with expanded polyQ regions, we ana- (Warrick et al., 1999). This suppression has been pro-
posed to occur by modulating soluble properties oflyzed early embryos expressing httex1-20Q, MJD-27Q,
MJD-78Q, httex1-93Q, and 127Q, using the early embry- pathogenic polyQ proteins, by preventing abnormal in-
teractions with other proteins, or by rescuing chaperoneonic GAL4 driver da-GAL4, which turns on at the blasto-
derm stage based on its UAS-GFP expression pattern depletion (Bonini, 2002). We tested whether expres-
sion of excess HSC70 protein would suppress axonal(data not shown).
Two considerations led us to evaluate the effects of blockages and neuronal cell death. Expression of UAS-
HSC70 using APPL-GAL4 in the presence of MJD-78QpolyQ proteins on available motor protein pools by as-
sessing soluble levels of motor proteins. First, if motor and 127Q restored axonal transport within larval nerves
and suppressed neuronal death (Figure 6A; Supplemen-proteins are titrated from normal cargoes by binding to
large aggregates, it may be difficult to distinguish motor tal Figure S4A at http://www.neuron.org/cgi/content/
full/40/1/25/DC1). PolyQ accumulations were absentproteins bound to sedimentable cargoes from sedi-
mentable aggregates. Second, it is not possible to mea- within larval nerves, while cytoplasmic and punctate
Neuron
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Figure 5. Expression of Pathogenic PolyQ Proteins Depletes the Amount of Soluble Motor Proteins
(A) Dramatic reduction is observed in the amount of soluble motor proteins, DHC, DIC, p150Glued, KHC, and KLC when MJD-27Q, MJD-78Q,
and 127Q are expressed; no change is observed in the amount of total motor proteins at 6 hr, using da-GAL4. A reduction in the amount of
soluble p150Glued and KLC is also seen when httex1-93Q is expressed. No change is seen in tubulin, actin, HDAC3, and Rab 8. Note that high
molecular weight aggregates containing DHC immunoreactivity are consistently observed in MJD-27Q, MJD-78Q, 127Q, and httex1-93Q
compared to wild-type.
(B) Expression of MJD-27Q, MJD-78Q, and MJD-77QNES are observed by anti-HA (asterisks), while MJD-77NES is also observed by anti-
polyQ staining. The levels of MJD-27Q and MJD-77QNES are significantly higher than observed in MJD-78Q.
(C) Immunoprecipitation with anti-HA reveals 127Q protein. Note that the high molecular weight MJD-77QNES aggregate can also be precipitated
by anti-HA.
(D) Dramatic reduction in the amount of soluble motor proteins is also observed in embryos expressing MJD-77QNES, similar to (A). High
molecular weight aggregate containing DHC is also evident with MJD-77QNES.
polyQ staining was present within larval brains (Figure Do Axonal Defects Instigate Neuronal Dysfunction?
The pathogenic polyQ proteins studied in the preceding6B). However, while these larvae were now able to pu-
pate (expression of MJD-78Q or 127Q alone causes sections accumulate in both axonal and nuclear inclu-
sions. To dissect the relative contributions of nucleardeath at second or third instar larval stages), they still
failed to eclose, suggesting that polyQ toxicity was still and axoplasmic inclusions to the phenotype, we used
transgenes that expressed proteins that had differentsufficient to cause lethality. Expression of HSC70 by
itself did not cause axonal blockages or neuronal cell subcellular localizations.
One transgene encoded a protein with an expandeddeath (data not shown). These results suggest that
chaperones could “clear” larval axons of blockages polyQ repeat with a nuclear localization sequence (MJD-
65QNLS). While expression of MJD-65QNLS within thecaused by polyQ proteins and suppress cell death within
the larval brain, although organismal toxicity was not larval brain caused neuronal apoptosis as observed by
TUNEL staining, organelle accumulations within larvalcompletely suppressed.
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Figure 6. Excess Chaperones Restore Neuronal Transport and Suppresses Cell Death Caused by Pathogenic PolyQ Proteins
(A) Overexpression of pathogenic polyQ proteins with excess HSC70 clears organelle accumulations and suppresses neuronal cell death.
Scale bar equals 10 m.
(B) Expression of excess HSC70 with pathogenic polyQ proteins leads to cytoplasmic polyQ staining within larval brains compared to nuclear
staining observed in brains expressing MJD-78Q alone (box enlarged on right; anti-polyQ, red; DAPI, blue).
axons were absent (Figure 7A). These larvae pupated had no effect on axonal transport. These findings em-
phasize that not all neuronal death is associated withbut failed to eclose. While reduction in dynein dose by
50% with excess MJD-65QNLS had no effect, reduction axonal accumulations, and that the axonal transport de-
fects induced by pathogenic polyQ proteins may bein kinesin dose by 50% with excess MJD-65QNLS
caused a small number of accumulations, perhaps due specific to cytoplasmic aggregations of expanded
polyQ proteins.to continued motor titration by these proteins even when
targeted to nuclei (Figure 7A). To test for cytoplasmic or axoplasmic toxicity, we
studied a protein with an expanded polyQ repeat withTo test further if dying neuronal cells induce axonal
transport defects, we also analyzed the axonal transport a nuclear export sequence (MJD-77QNES). Expression
of MJD-77QNES within larval neurons caused largephenotype of the cell death gene reaper, which also
induces neuronal apoptosis. Transport following reaper numbers of synaptotagmin-containing organelle accu-
mulations within larval nerves (Figure 7B). Consistentexpression in these genotypes appeared to be normal
based on immunostaining with synaptic vesicle markers with primarily cytoplasmic localization of this protein,
polyQ/HA staining was absent from cell nuclei withineven though high levels of neuronal apoptosis were in-
duced (Supplemental Figure S4B at http://www.neuron. the larval brain, with bright anterior staining (just distal
to the brain) present within larval nerves (Figure 7D;org/cgi/content/full/40/1/25/DC1). In addition, a 50% re-
duction in KHC combined with excess reaper expression compare to nuclear polyQ expression in MJD-78Q [Fig-
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Figure 7. Axonal Transport Defects Caused by Pathogenic PolyQ Proteins Are Specific to Cytoplasmic Aggregations
(A) Expression of MJD-65QNLS does not cause organelle accumulations within larval nerves as observed by CSP, but causes neuronal cell
death as observed by TUNEL within the brain. PolyQ staining is observed within brains. 50% reduction in KHC with MJD-65QNLS shows
some organelle accumulations (also see C) while 50% reduction in DLC has no effect.
(B) Expression of MJD-77QNES causes organelle accumulations, which are enhanced by 50% reduction in KHC. Anti-SYT, green; anti-polyQ,
red. Scale bar equals 10 m.
(C) Quantitative analysis indicates that the extent of accumulations in MJD-77QNES is comparable to homozygous mutations of motor proteins.
50% reduction in KHC with MJD-77QNES enhances this phenotype, while 50% reduction in DLC causes early larval lethality (asterisk).
(D) Expression of MJD-77QNES does not cause TUNEL-positive nuclei within the brain, and polyQ staining is not observed within neuroblast
nuclei as in MJD-78Q. Bright polyQ staining is observed within larval nerves (compare to Figure 6B; DAPI, green; anti-polyQ, red).
(E) Expression of MJD-77QNES within the adult eye using GMR-GAL4 shows degeneration, including complete loss of pigmentation compared
to MJD-27Q.
Axonal Transport and PolyQ Proteins
35
ure 6B] or MJD-65QNLS [Figure 7A]). Neuronal apopto- This transport is critical to support signaling and other
aspects of neuronal viability and function. We previouslysis as determined by TUNEL staining was completely
found that disruption of axonal transport by proteinsabsent (Figure 7D) and these larvae died at second or
implicated in Alzheimer’s disease can cause neuronalthird instar, similar to MJD-78Q. Quantitative analysis
cell death, suggesting that axonal transport perturbationindicates that the extent of organelle accumulations
may play a role in neurodegenerative disease. Here wewithin MJD-77QNES is comparable to accumulations
tested whether proteins that cause polyQ expansionobserved in mutations of motor proteins, suggesting
diseases could also cause defects in axonal transportthat perhaps the extent of accumulations causes lethal-
pathways. We found that wild-type htt is needed fority (Figure 7C). Similar to MJD78Q, a 50% reduction in
normal axonal transport. In addition, pathogenic polyQthe dose of KHC with MJD-77QNES enhanced organelle
proteins alone, or in the context of human htt exon 1blockages (Figures 7B and 7C), while 50% reduction in
or the MJD C terminus, can interfere with the axonalDLC combined with MJD-77QNES caused early larval
transport machinery and cause neuronal apoptosis andlethality. Additionally, expression of MJD-77QNES in the
organismal death (Table 1). Thus, our findings demon-adult eye using GMR-GAL4 caused a severe degenera-
strate that pathogenic polyQ proteins can poison thetive eye phenotype, indicating that cytoplasmic polyQ
axonal transport system and support the proposal thatprotein can cause degeneration of adult neurons (Fig-
defects in axonal transport may contribute to neuronalure 7E).
failure in HD and other polyQ expansion diseases.To directly test if excess MJD-77QNES sequestered
An important concern in interpreting our data ismotor proteins, we compared embryos expressing
whether the transport failures we observe are causedMJD-27Q, MJD-78Q, and MJD-77QNES with wild-type
by direct poisoning of the transport machinery by patho-(da-GAL4). While embryos expressing both MJD-78Q
genic polyQ proteins, or if it is an indirect consequenceand MJD-77QNES showed normal levels of total motor
in neurons that have become sick or are dying fromproteins, they exhibited a striking reduction in the
other causes. There are four strong arguments that sup-amount of soluble motor proteins (Figure 5D). MJD-
port the interpretation that pathogenic polyQ proteins77QNES also exhibited high molecular weight aggre-
themselves poison the transport machinery leading togates, which could be immunoprecipitated with the HA
neuronal failure. First, two different screens for axonalantibody (Figures 5B and 5C). These high molecular
transport mutants in our lab suggest that this phenotypeweight aggregates also contained sequestered DHC
is relatively rare. In one screen, only 4 out of 12,000(Figures 5A and 5D). Although phenotypically normal
mutagenized chromosomes exhibited a phenotype di-when expressed in larvae, MJD-27Q appears to titrate
agnostic of transport abnormalities, namely abnormalmore DHC into high molecular weight aggregates than
larval motility combined with organelle accumulationsdo MJD-78Q, MJD-77QNES, or 127Q. It is conceivable
in axons (Bowman et al., 1999, 2000). In a recent screen,that pathogenic MJD-78Q, MJD-77QNES, and 127Q
446 out of 13,000 mutants exhibited the larval motilityform high molecular weight aggregates that we are un-
phenotype. 114 of these were tested for organelle accu-able to trap or to solubilize in our current protocols.
mulations in axons, but only 3 were found to exhibit thisIndeed, dramatic phenotypes are only observed in MJD-
phenotype (M. Haghnia and L.S.B.G., unpublished data).78Q, MJD-77QNES, and 127Q (Figures 3A and 7B). Addi-
In this context, among mutations where the gene prod-tionally, similar to embryos expressing MJD-78Q or
uct is known, only mutations in genes encoding motor127Q, embryos expressing MJD-77QNES died soon
protein subunits, or genes encoding proteins whereafter they hatch into larvae, indicating significant polyQ
there is strong evidence to support a role in the transporttoxicity on normal development. It is possible that the
machinery, cause this phenotype. Second, an over-“soluble” polyQ aggregates we observe in embryos ex-
expression screen using EP elements yielded 36 linespressing MJD-77QNES represent a subclass of mis-
that had the larval motility phenotype out of 2300 tested
folded proteins, while the class of insoluble aggregates,
when driven with 179Y-GAL4; only 3 of these had organ-
which we are unable to observe directly on SDS-PAGE,
elle accumulations within their axons (S.G. and L.S.B.G.,
may be responsible for polyQ toxicity. unpublished data). Third, we previously showed that
To distinguish if MJD-78Q blockages and MJD- overexpression of GFP, or of any protein lacking the C
77QNES blockages are comparable, we tested whether terminus of APP relatives (which is thought to interact
blockages caused by MJD-77QNES expression can be with the transport machinery), did not cause a transport
suppressed by excess HSC70. Expression of MJD- phenotype (Gunawardena and Goldstein, 2001). In our
77QNES with excess HSC70 completely suppressed current analysis of proteins implicated in polyQ expan-
axonal accumulations, polyQ aggregates, and rescued sion diseases (Table 1), we observed similar phenotypic
larval lethality to pupae, suggesting that axonal selectivity. Proteins with short polyQ regions do not
blockages caused by either MJD-78Q or MJD-77QNES cause transport failures unless motor protein dosage
were comparable (Figure 6A). PolyQ-containing accu- is reduced. Fourth, induction of neuronal apoptosis by
mulations were also absent in larval nerves. However, excess expression of the cell death gene reaper failed
excess HSC70 was not sufficient to suppress organis- to cause axonal transport problems. Expression of MJD-
mal lethality. 65QNLS, which primarily targets to the nucleus and in-
duces apoptosis, also did not cause transport failures.
Discussion Thus, cell death or sick cells do not generally cause
axonal transport defects.
Within axons, vital neuronal cargoes must be trans- If expression of pathogenic polyQ proteins directly
causes transport failures, what might be the mecha-ported over great distances along microtubule tracks.
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Table 1. Summary of Constructs, Mutants, and Phenotypes
Axonal Transport Phenotype APPL-GAL4 Eye Degeneration Phenotype GMR-GAL4
Normal Kinesin, 50% Reduction 50% Reduction Normal Kinesin,
Normal Dynein in Kinesin in Dynein Normal Dynein
dhtt RNAi Knockout Lines JAMS deatha ↑JAMS death JAMS death yes
UAS Transgenic Lines
20Q normal normal normal no (Kazemi-Esfarjani and Benzer, 2000)
httexon1 20Q normal normal normal no (Steffan et al., 2001)
22Q normal normal JAMS no death no (Marsh et al., 2000)
MJD-27Q normal normal JAMS no death no (Warrick et al., 1998)
MJD-65QNLS No JAMS death JAMS no effect ND
MJD-77QNES JAMS death ↑JAMS no death larval lethal yes
MJD-78Q JAMS death ↑JAMS ↑death larval lethal yes (Warrick et al., 1998)
httexon1 93Q JAMS death ↑JAMS ↑death JAMS death yes (Steffan et al., 2001)
108Q JAMS death ↑JAMS ↑death larval lethal yes (Marsh et al., 2000)
127Q JAMS death ↑JAMS ↑death larval lethal yes (Kazemi-Esfarjani and Benzer, 2000)
reaper No JAMS death no effect ND yes
a Death refers to neuronal cell death.
nism? One possibility is that aggregation of pathogenic Drosophila system (compare Figure 4A to Figure 4 in Li
et al., 2001). Similarly, axonal abnormalities, perinuclearpolyQ proteins in narrow axons can physically impair
transport of large organelles or vesicles. While attrac- and nuclear accumulations, with severe dysfunction in
mechanosensory neurons were observed in C. eleganstive, this possibility on its own does not easily account
for the observation that polyQ proteins with repeat expressing pathogenic polyQ repeats in the context of
htt (Parker et al., 2001). In addition, axonopathies arelengths that are not pathogenic can cause transport
failures when combined with reductions in motor protein prominent in a number of polyQ expansion diseases (Li
et al., 2000), and this view also accounts for the benefi-gene dose (e.g., MJD-27Q; Supplemental Figure S2A at
http://www.neuron.org/cgi/content/full/40/1/25/DC1). cial effects of chaperone increases upon transport phe-
notypes. Live analysis also showed the accumulation ofIn addition, recent work argues that aggregation per se
may not be required for neuronal toxicity (Klement et YFP-tagged vesicles into nonmotile aggregates in axons
of larvae expressing expanded polyQ repeats. Thisal., 1998; Yoo et al., 2003). A second possibility is that
titration of motor proteins from other critical pathways mechanism would also suggest that there is a pheno-
typic continuum caused by motor protein reductions orinduces vesicle stalling during transport in narrow ax-
ons, which can nucleate organelle accumulations that physical aggregation where the burden of either one
alone, if substantial enough, can cause phenotypes.block subsequent transport. While this possibility ac-
counts for the observed ability of pathogenic polyQ pro- However, the relative extent to which axonal blockages
contribute to transport failure as compared to motorteins to significantly reduce the soluble pool of motor
proteins we observe, it does not easily account for the protein depletion needs to be investigated further. We
also note that this proposal has the virtue that it providesability of short polyQ repeats to titrate motor proteins
without causing transport failure. The third possibility, a plausible explanation for the otherwise puzzling ability
of broadly expressed proteins to cause neuron-specificwhich we favor, is that motor protein titration and a
propensity to aggregate and physically block transport toxicity in human disease. Thus, it is conceivable that
defects in axonal pathways may contribute to early dis-in narrow axons act in concert to poison axonal trans-
port. This mechanism, while more complex than the ease neuropathology.
others, best accounts for a number of important obser-
vations including those that are not easily explained The Normal Functions of Huntingtin
We provide direct evidence that htt is required for normalby the simplest models. For example, this mechanism
accounts for the observed ability of short polyQ repeats axonal transport. Neuronal depletion of Drosophila htt
using RNAi caused an axonal blockage phenotype,to titrate soluble motor proteins but to poison the trans-
port machinery only when motor protein gene dosage is which is characteristic of mutations not only in cytoskel-
etal motor proteins that are required for axonal trans-further reduced. It is also consistent with the observation
that motor protein gene dosage generally needs to be port, but also in proteins that function as receptors for
motors (Bowman et al., 2000; Gunawardena and Gold-reduced by more than 50% to cause significant trans-
port phenotypes. This mechanism also accounts for our stein, 2001). These axonal blockages were enhanced by
a 50% reduction in kinesin. Loss of htt in the eye caused(e.g., Figure 3A) and others’ observations (Piccioni et
al., 2002; Li et al., 2000, 2001) that expression of polyQ a distinct degenerative phenotype similar to what has
been observed in weak mutations of DLC (Bowman etproteins in neurons causes axonal inclusions that con-
tain the polyQ proteins themselves. EM examination of al., 1999), DIC, and heterozygous dominant mutations
of p150Glued (Boylan et al., 2000). Until now, previous workthe ultrastructure of these inclusions in a mouse model
of HD revealed a morphology of accumulated vesicles, has only hinted at a possible transport function for htt
but provided no direct evidence in support of this impor-organelles, and distended axons that is virtually identical
to what we observe in axonal blockages formed in the tant proposal. For example, mouse models of HD and
Axonal Transport and PolyQ Proteins
37
conditional htt knockout mice all exhibited degeneration the first, polyQ-induced cytoplasmic perturbations in
axonal transport pathways could directly instigate neu-of axon fibers, compatible with, but not establishing,
a function for htt in axonal transport (Dragatsis et al., ronal failure and organismal death. In the second, accu-
mulation of pathogenic polyQ proteins within the nu-2000; DiFiglia et al., 1997; Hodgson et al., 1999; Li et
al., 2000). Thus, our data together with htt localization cleus (perhaps enhanced by axonal blockages) and
events triggered by the nuclear presence of pathogenicdata strongly support a functional role for htt in fast
axonal transport. Although how htt associates with the polyQ protein could trigger neuronal death, neuronal
degeneration, and finally organismal death. These ideasaxonal transport machinery is still unclear, we propose
that a subclass of vesicles containing htt may associate are consistent with recent findings on the androgen re-
ceptor, which, when expanded by a polyQ stretch inwith motor proteins via HAP1, or a similar protein, which
establishes the link between htt and p150Glued, thereby the N-terminal A/B domain, causes spinal and bulbar
muscular atrophy (SBMA), an X-linked, adult-onset neu-enabling transport. Although a true Drosophila homolog
of HAP1 is yet to be identified, Drosophila Milton is rodegenerative disorder. While expression of expanded
polyQ repeats in the context of the androgen receptorrelated to HAP1 and has been suggested to be required
for kinesin-dependent transport of mitochrondria (Stow- also caused neuropil aggregates and altered the distri-
bution of kinesin (Piccioni et al., 2002), abnormal bindingers et al., 2002). In addition, many coiled-coil linker pro-
teins exist that could facilitate this connection. of the ligand, androgen, to polyQ-expanded human an-
drogen receptor caused neurodegeneration due to li-Our proposal that htt is required for axonal transport
explains why both reduction and gain of function cause gand-dependent structural alteration that promoted nu-
clear translocation (Takeyama et al., 2002). Thus, it issimilar phenotypes, since both can lead to failures of
vesicle transport that might physically and biochemi- possible that pathogenic polyQ proteins cause polyQ-
induced cytoplasmic accumulations and these accumu-cally cause organelle blockages in axons. For example,
in mouse models, both loss (Dragatsis et al., 2000) and lations may promote abnormal protein-protein inter-
actions that could trigger a cascade of toxic events,gain of function of htt causes neurodegeneration (Man-
giarini et al., 1996; Difiglia et al., 1997; Li et al., 2000) ultimately leading to neurodegeneration and organismal
death. Indeed, a recent study suggests that solubleand axonal pathology (Sapp et al., 1999; Li et al., 2000,
2001). It is striking that in the Drosophila system too, oligomers, which are common to most aggregate form-
ing diseases, may be cytotoxic (Kayed et al., 2003).both loss of htt function and polyQ-induced gain of func-
tion cause similar axonal blockage phenotypes includ- Both polyQ toxicity (Warrick et al., 1999; Kazemi-
Esfarjani and Benzer, 2000) and -synuclein toxicity (Au-ing neurodegeneration in the adult eye, which may result
due to disruption of a specialized neuronal pathway. luck et al., 2002) observed in the Drosophila adult eye
and brain are dramatically modulated by excess chaper-Both processes could contribute to the observed re-
duced trafficking of the neurotrophic factor BDNF in ones. It is conceivable that polyQ toxicity within axons
is also modulated by chaperones. Indeed, we found thatmouse HD brains (Zuccato et al., 2001). Indeed, HD is
a dominantly inherited disease with both homozygous axonal blockages and neuronal cell death were com-
pletely suppressed by excess HSC70 together in trans-and heterozygous individuals affected similarly by a
gained toxic function. genic lines expressing expanded polyQ repeats, although
organismal lethality still persisted. The chaperone inter-
action with misfolded mutant polyQ protein may preventNuclear versus Cytoplasmic Mechanisms
abnormal interactions with motor proteins and otherof PolyQ Diseases
proteins, thereby preventing organelle blockages withinAn important point of controversy is whether neuronal
axons and neuronal death. Consistently, cytoplasmictoxicity in HD and other polyQ diseases results from
axonal aggregations caused by excess polyQ repeatsnuclear or cytoplasmic events. We found that polyQ-
with NES were also suppressed by chaperone expres-induced disease pathogenesis can occur via two mech-
sion, although organismal lethality still occurred. Lethal-anisms—one that induces apoptosis by nuclear accumu-
ity, however, may result due to the fact that althoughlation, and the other that induces neuronal dysfunction
chaperones are modulating abnormal or misfolded pro-by disrupting axonal transport, although these two path-
teins, they may be unable to completely prevent theways may not be mutually exclusive. PolyQ-induced
toxic activity of abnormal aggregations of disease pro-neuronal death did not result upon expression of a
tein in time for normal development to proceed.pathogenic polyQ protein restricted to the cytoplasm
by the addition of a nuclear export signal (NES), although
axonal blockages formed and organismal death resulted. Is Axonal Transport a Common Target
in Aggregation Disorders?In contrast, expression of a nuclear-targeted polyQ pro-
tein (NLS) caused nuclear accumulations, apoptosis, Protein aggregation appears to be a common manifesta-
tion in many neurodegenerative diseases, and increas-and lethality. These findings suggest that translocation
of polyQ protein into the nucleus is required for cell ing evidence suggests that such accumulations can be
a major trigger of cellular stress and neuronal deathdeath and that cytoplasmic polyQ proteins can cause
axonal blockage. In fact, similar to the situation of polyQ (Wyss-Coray and Mucke, 2002). In Alzheimer’s disease,
accumulation of the 4 kDa A fragment in amyloidproteins without an NES, a 50% reduction in kinesin-
enhanced organelle blockages and a 50% reduction in plaques and aggregation of phosphorylated Tau in neu-
rofibillary tangles is observed surrounded by degenerat-dynein caused early organismal lethality of polyQ-NES
expressing animals. Taken together, our data support ing neurites; deposits of aggregated prion proteins with
amyloid-like structures are observed in mad cow ortwo pathways for pathogenesis by polyQ proteins. In
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were used. Female tubby siblings were used as controls. ControlCreutzfeld-Jacobs disease; in Parkinson’s disease, ab-
experiments were done by crossing the above males to Oregon-Rnormal -synuclein accumulations known as Lewy bod-
females. UAS-RhoGAP RNAi, UAS-HSC70, and UAS-reaper linesies are seen; and in HD and other expanded polyQ dis-
were obtained from Bloomington.
eases, abnormal accumulations of mutant protein are
observed as nuclear and sometimes axonal inclusions. Generation of RNAi Knockout of Drosophila Huntingtin
The widespread occurrence of axonal (or dendritic) in- The UAS double-strand htt hairpin construct was generated similar
to Piccin et al., 2001. The inverted repeat RNAi clone utilized twoclusions leads us to wonder whether perturbations in
1 kb PCR-amplified fragments from the EST clone LD23533 corre-transport could be a common pathway in neurodegener-
sponding to the 5 end of the Drosophila htt gene (CG9995). A 300ative disease. In support of this idea, recent findings
bp GFP linker fragment was PCR amplified from the GFP vectorindicate that dynein and dynactin mutations can induce
(Clonetech). Fragments were cloned into pBS.SK (Strategene) in a
motor neuron degeneration in mice and humans (Ha- three part ligation. The 2.3 kb EagI/KpnI fragment was excised and
fezparast et al., 2003; Puls et al., 2003). cloned into pUAST; identity and orientation were confirmed by di-
gests and sequence analysis. P element-mediated germline trans-In this context, the strongest evidence comes from
formation was performed using yw as the parental stain. A total ofHD, which is characterized by the preferential loss of
eight lines were obtained and three lines (dhtt#1, dhtt#9, andstriatal neurons. Strikingly, htt accumulations are found
dhtt#13) were used for tissue-specific RNAi knockout experiments.in axons of striatal projection neurons (Li et al., 2001),
and it has been argued that these striatal axonal inclu- RT-PCR and RNA Quantitative Analysis
sions are better correlated with striatal neuron loss than To determine the extent of RNAi knockout of the Drosophila htt
the presence of nuclear inclusions. Expression of ex- gene, total RNA was isolated from single yw, APPL-GAL4;dhtt#1,
APPL-GAL4;dhtt#9, and APPL-GAL4;dhtt#13 larval brains usingpanded polyQ repeats in the context of the androgen
RNeasy (Qiagen). Any remaining DNA was removed using DNA-freereceptor also forms neuropil aggregates and alters the
system (Ambion). First strand cDNA synthesis was performed usingdistribution of kinesin (Piccioni et al., 2002), further sup-
superscript system for RT-PCR (Invitrogen). PCR was done using
porting the idea that early pathology can occur within HotStart Taq (Qiagen) using two sets of HD primers corresponding
axonal processes together with axonal inclusions. It is to the middle and the 3 end of the gene to amplify a 156 bp and a
possible that wild-type htt is required for efficient vesicle 349 bp fragment of the htt gene. As a control, a 500 bp fragment
of the ELAV gene was amplified. Intensity versus exposure time andtrafficking of cortical BDNF, since mutant htt interfered
intensity versus loading were analyzed and determined to be linearwith its anterograde transport, contributing to BDNF
using line plot analysis on the Stratagene Eagle Eye II system (datadepletion in the striatum (Cattaneo et al., 2001). The
not shown). The best intensity range was selected and used to
importance in transport of neurotrophic factors is also measure intensity of PCR bands from experimental brains.
evident in Alzheimer’s disease, where one of the earliest
detectable signs of disease is the loss of synapses and Cell Immunohistochemistry and Histology
retrograde degeneration of neurons, accompanied by Larvae were dissected, fixed, immunostained, and analyzed as de-
scribed in Gunawardena and Goldstein (2001). Synaptic vesiclethe decay of intracellular traffic (Terry, 2000). In addition,
markers anti-DSYT2 (Hugo Bellen) and anti-CSP (Konrad Zinsmaier)excess of APP proteins containing the toxic A region
were used. Anti-polyQ (Chemicon) and anti-HA (Roche and Santaperturbed axonal transport pathways and caused neu-
Cruz) were used at 1:100. For histology, adult heads were prepared
ronal cell death (Gunawardena and Goldstein, 2001). for light microscopy as described in Warrick et al. (1998).
Thus, we propose that perturbation in axonal transport Embryos were generated by crossing da-GAL4 females to UAS-
can contribute to early disease pathology owing to dis- MJD-27Q, UAS-MJD-77QNES, UAS-MJD-78Q, UAS-20Q, UAS-
127Q, or yw males at 29C. 6 hr and 12 hr embryo collections wereruption in proper transport of essential neuronal compo-
dechorionated and fixed as described in Gunawardena and Rykow-nents, triggering a cascade of events leading to neuronal
ski (1994). Briefly, embryos were washed in 50% bleach in ddH20failure and death.
and fixed in heptane, 1 PBS, and 4% formaldehyde (16%, TED
PELLA). Embryos were incubated overnight in anti-polyQ. DAPI (0.1
g/ml; Sigma)-stained embryos were mounted in VectashieldExperimental Procedures
mounting medium (Vector Labs) and observed under a BIO-RAD
MRC1024 confocal micoscope. No noticeable developmental de-Drosophila Stocks
lays were observed during embryogenesis (data not shown).UAS-MJD-27Q and UAS-MJD-78Q have been previously described
For TUNEL analysis, larval brains were carefully dissected. Detec-(Warrick et al., 1998). The NES sequence from the Rev protein (Meyer
tion of apoptotic neuronal cells was performed as previously de-and Malim, 1994) was added to the 3 end of the MJD-78Q sequence
scribed (Gunawardena and Goldstein, 2001).(Warrick et al., 1998) and subcloned into the pUAST vector (B.G.-G.
For electron microscopy, larvae were dissected, fixed, stained,and N.M.B., unpublished data), and the injected construct had 77Q
and cut as previously described in Bowman et al. (1999).repeats. A polyQ construct with an added NLS (Perez et al., 1998)
was subcloned into pUAST, and the injected construct had 65Q
Live Analysis of Vesicle Transport within Larval Axonsrepeats (B.G.-G. and N.M.B., unpublished data). UAS-20Q and UAS-
The APP-YFP construct (Carlos Dotti) was excised and cloned into127Q were obtained from Dr. Seymour Benzer (Caltech), and UAS-
pUAST and injected as described. APP-YFP/Y;GAL4/ males were22Q, UAS-108Q httex1-20Q, and httex1-93Q were obtained from
crossed to homozygous UAS-MJD-78Q females. Larvae were dis-Dr. Leslie Thompson (University of California, Irvine). Transgenic lines
sected as described and axonal transport was visualized live atwere expressed using APPL-GAL4 (Gunawardena and Goldstein,
100 magnification on a Nikon TE2000U microscope. Images were2001), 179Y-GAL4, daughterless-GAL4, and GMR-GAL4 (Bloomington)
captured using a Cool Snap HQ cooled CCD camera and Metamorphat 29C unless otherwise stated. The onset of APPL-GAL4 and daugh-
imaging system v.6.0 (Universal Imaging Corporation).terless-GAL4 was determined by crossing these to UAS-GFP
(Bloomington). Genetic interaction tests were performed as in Guna-
wardena and Goldstein (2001). Males that were APPL-GAL4/Y;khc8/ Protein Extraction, Immunoprecipitation,
and Western AnalysisB3, APPL-GAL4/Y;Df(3L)8ex94 (KLC)/B3, APPL-GAL4/Y;roblk/B3, APPL-
GAL4/Y;Df(3L)GN24 (DHC)/B3, APPL-GAL4/Y;Df(3R)ry615 (Arp1)/B3, 6 hr and 12 hr aged embryos were dechorionated and homogenized
in Buffer A (250 mM sucrose, 15 mM Tris-HCl [pH 7.9], 60 mM KCl,APPL-GAL4; Df(3L)fz-GF3b (p150Glued)/B3, or APPL-GAL4/Y;l(2)k16109
(Dmn)/B3 were crossed to females from UAS lines and only females 15 mM NaCl, 5 mM EDTA, 1 mM EGTA, 0.5 mM DTT, and protease
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inhibitors). Lysate was centrifuged at 4000  g for 10 min. Superna- developments in Huntington’s disease research. Trends Neurosci.
24, 182–188.tant was centrifuged at 18,000  g for 10 min and the second
supernatant was collected. Samples were loaded on 4%–12% Bis- DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young,
Tris NuPage gels (Invitrogen) and transferred to Immobilon-P mem- C., Martin, E., Vonsattel, J.P., Carraway, R., Reeves, S.A., et al.
brane (Millipore). Anti-Drosophila p150Glued (Erika Holzbaur), anti- (1995). Huntingtin is a cytoplasmic protein associated with vesicles
Drosophila DHC (Tom Hayes), anti-DIC (Chemicon), anti-Drosophila in human and rat brain neurons. Neuron 14, 1075–1081.
KHC (Bill Saxton), anti-Drosophila KLC, anti-HDAC3 (BD Biosci-
DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsat-
ence), anti-Rab8 (BD Bioscience), anti--tubulin (Sigma), anti-actin
tel, J.P., and Aronin, N. (1997). Aggregation of huntingtin in neuronal
(Boehringer Mannheim), anti-polyQ (Chemicon), and anti-HA (Roche)
intranuclear inclusions and dystrophic neurites in brain. Science
were used as recommended. Respective secondary antibodies were
277, 1990–1993.
used and detected using ECL (Amershan Pharmacia). For immuno-
Dragatsis, I., Levine, M.S., and Zeitlin, S. (2000). Inactivation of Hdhprecipitation, 500g of lysate was precleared with 50l of protein-G
in the brain and testis results in progressive neurodegeneration andbeads (Roche). 1 g of antibody was added to supernatant and
sterility in mice. Nat. Genet. 26, 300–306.incubated. 20 l of BSA-blocked protein-G beads were added and
Duyao, M.P., Auerbach, A.B., Ryan, A., Persichetti, F., Barnes, G.T.,incubated. The beads were washed in cold Buffer A and 30 l of 1
McNeil, S.M., Ge, P., Vonsattel, J.P., Gusella, J.F., Joyner, A.L.,LDS-sample buffer (Invitrogen) was added to beads and analyzed by
et al. (1995). Inactivation of the mouse Huntington’s disease geneWestern blot analysis.
homolog Hdh. Science 269, 407–410.
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